Cargando…

On the Effect of Thermodynamic Equilibrium on the Assembly Efficiency of Complex Multi-Layered Virus-Like Particles (VLP): the Case of Rotavirus VLP

Previous studies have reported the production of malformed virus-like-particles (VLP) in recombinant host systems. Here we computationally investigate the case of a large triple-layered rotavirus VLP (RLP). In vitro assembly, disassembly and reassembly data provides strong evidence of microscopic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roldão, António, Mellado, Maria Candida M., Lima, J. C., Carrondo, Manuel J. T., Alves, Paula M., Oliveira, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280969/ https://www.ncbi.nlm.nih.gov/pubmed/22359487 http://dx.doi.org/10.1371/journal.pcbi.1002367

Ejemplares similares

Large-scale production and purification of VLP-based vaccines
por: Vicente, Tiago, et al.
Publicado: (2011)

VLP‐factory™ and ADDomer(©): Self‐assembling Virus‐Like Particle (VLP) Technologies for Multiple Protein and Peptide Epitope Display
por: Sari‐Ak, Duygu, et al.
Publicado: (2021)

Erythro-VLP: Erythrocyte Virus-Like-Particles
por: Himbert, Sebastian, et al.
Publicado: (2021)

Dissecting insect cell heterogeneity during influenza VLP production using single-cell transcriptomics
por: Silvano, Marco, et al.
Publicado: (2023)

Zika virus-like particle (VLP) based vaccine
por: Boigard, Hélène, et al.
Publicado: (2017)

Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
por: Ruzzi, Francesca, et al.
Publicado: (2023)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

Gene Expression Analysis of Adapted Insect Cells during Influenza VLP Production Using RNA-Sequencing
por: Silvano, Marco, et al.
Publicado: (2022)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
por: Klimek, Ludger, et al.
Publicado: (2018)

Interaction between Borrelia miyamotoi variable major proteins Vlp15/16 and Vlp18 with plasminogen and complement
por: Schmidt, Frederik L., et al.
Publicado: (2021)

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
por: Torresi, Joseph
Publicado: (2017)

RNA Phage VLP-Based Vaccine Platforms
por: Peabody, David S., et al.
Publicado: (2021)

Isotype-specific antibody responses to rotavirus and virus proteins in cows inoculated with subunit vaccines composed of recombinant SA11 rotavirus core-like particles (CLP) or virus-like particles (VLP)
por: Fernandez, F.M., et al.
Publicado: (1996)

Preparation of SARS-CoV-2 VLP to study viral assembly, egress, and entry
por: Petersen, Jennifer D., et al.
Publicado: (2022)

Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions
por: Antanasijevic, Aleksandar, et al.
Publicado: (2016)

Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice
por: Zhou, Hongli, et al.
Publicado: (2011)

Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines
por: Fernandez, F.M., et al.
Publicado: (1998)

VLP-Based Vaccines as a Suitable Technology to Target Trypanosomatid Diseases
por: Queiroz, Aline Maria Vasconcelos, et al.
Publicado: (2021)

A thermostable, chromatographically purified Ebola nano-VLP vaccine
por: Carra, John H, et al.
Publicado: (2015)

Establishment of a yeast-based VLP platform for antigen presentation
por: Wetzel, David, et al.
Publicado: (2018)

Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
por: Hankaniemi, Minna M., et al.
Publicado: (2020)

A Hydrodynamic Approach to the Study of HIV Virus-Like Particle (VLP) Tangential Flow Filtration
por: Wolf, Tobias, et al.
Publicado: (2022)

Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery
por: Sánchez-Sánchez, Lorena, et al.
Publicado: (2015)

A DNA inducing VLP vaccine designed for HIV and tested in mice
por: Calazans, Alexandre, et al.
Publicado: (2017)

Passive Immunity and Antibody Response Induced by Toxoplasma gondii VLP Immunization
por: Kang, Hae-Ji, et al.
Publicado: (2021)

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
por: Pankrac, Joshua, et al.
Publicado: (2018)

Human Papillomavirus Type16- L1 VLP Production in Insect Cells
por: Abdoli, Asghar, et al.
Publicado: (2013)

Retraction: A DNA inducing VLP vaccine designed for HIV and tested in mice
Publicado: (2018)

Host Protein BAG3 is a Negative Regulator of Lassa VLP Egress
por: Han, Ziying, et al.
Publicado: (2018)

VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation
por: Daly, Seth M., et al.
Publicado: (2017)

Computational Design of a Novel VLP-Based Vaccine for Hepatitis B Virus
por: Mobini, Saeed, et al.
Publicado: (2020)

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)
por: Huber, Bettina, et al.
Publicado: (2017)

Virus-like Particle (VLP) Mediated Antigen Delivery as a Sensitization Tool of Experimental Allergy Mouse Models
por: Kim, Juhyung, et al.
Publicado: (2020)

A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines
por: Goksøyr, Louise, et al.
Publicado: (2022)

Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer
por: Donaldson, Braeden, et al.
Publicado: (2017)

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
por: Cabral-Miranda, Gustavo, et al.
Publicado: (2018)

Therapeutic immunisation of rabbits with cottontail rabbit papillomavirus (CRPV) virus-like particles (VLP) induces regression of established papillomas
por: Govan, Vandana A, et al.
Publicado: (2008)

Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus
por: Garg, Himanshu, et al.
Publicado: (2020)

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
por: Chu, Ki-Back, et al.
Publicado: (2021)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j7klhejfkk8bb0mkfrb1rtj5nb